Nissan's most popular car in Europe has finally arrived in America
Nissan
The Rogue Sport is the US version of the award-winning Qashqai (pronounced Cash-Kai) crossover - Nissan's hottest selling model in Europe.
Even though the Rogue Sport is built on the same Renault-Nissan CMF platform as the Rogue, it's more than a foot shorter.
As a result, the Rogue Sport will target young singles, couples without kids, and empty nesters.
"While we expect Rogue to continue to appeal to owners with young families, Rogue Sport fills a need for singles and couples who want more space and versatility than the average sedan for everyday urban use and social activities, " Nissan North America vice president for product planning, Michael Bunce, said in a statement.
Nissan
The Rogue sport will also be equipped with Nissan's suite of connected services, surround view camera system, and intelligent cruise control.
Rumors of the Qashqai's arrival in the US have been making the rounds for a couple of years now. According to Nissan, it chose to delay the arrival of the Qashqai in order to focus on building up the strength of the Rogue brand.
In 2016, sales of the larger Rogue surged nearly 15% - with more than 329,000 units sold in the US. In fact, it became the 10th best selling vehicle in the country and managed to overtake the Altima sedan to become Nissan's best selling model.
Nissan
Nissan has not yet released its 2016 sales figures for Europe, however, the latest numbers from November show that the Qashqai is, far and away, the brand's most popular model. In 2015, Nissan sold 251,000 Qashqais in Europe. The Juke finished second with just 109,000 vehicles sold.
The 2017 Rogue Sport will reach US showrooms in the spring. Nissan has not yet announced official pricing.
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Kotak Mahindra Bank shares tank 13%; mcap erodes by ₹37,721 crore post RBI action
- Rupee falls 6 paise to 83.39 against US dollar in early trade
- Markets decline in early trade; Kotak Mahindra Bank tanks over 12%
- An Ambani disruption in OTT: At just ₹1 per day, you can now enjoy ad-free content on JioCinema
- Data Analytics for Decision-Making